FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bracha Rager-Zisman

Research Profile

Living Beings

Anatomy

Physiology

Chemicals & Drugs

Disorders

Geographic Areas

Israel

Co-author Network

Publications

TOP 3
Bracha Rager-Zisman
Ethical and regulatory challenges posed by synthetic biology.
Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzchak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
David Friedman; Bracha Rager-Zisman; Eitan Bibi; Alex Keynan
The bioterrorism threat and dual-use biotechnological research: an Israeli perspective.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bracha Rager-Zisman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bracha Rager-Zisman
Ethical and regulatory challenges posed by synthetic biology.
Perspectives in biology and medicine 2012;55(4):590-607.
2010: Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzchak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
Immunology 2010;130(4):527-35.
2010: David Friedman; Bracha Rager-Zisman; Eitan Bibi; Alex Keynan
The bioterrorism threat and dual-use biotechnological research: an Israeli perspective.
Science and engineering ethics 2010;16(1):85-97.
2009: Oren Hershkovitz; Benyamin Rosental; Lior Ann Rosenberg; Martha Erika Navarro-Sanchez; Sergey Jivov; Alon Zilka; Orly Gershoni-Yahalom; Elodie Brient-Litzler; Hugues BEDOUELLE; Joanna W Ho; Kerry S Campbell; Bracha Rager-Zisman; Philippe Despres; Angel Porgador
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2610-21.
2009: Shahar Robinzon; Avis Dafa-Berger; Mathew D Dyer; Bryan Paeper; Sean C Proll; Thomas H Teal; Slava Rom; Daniel Fishman; Bracha Rager-Zisman; Michael G Katze
Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus.
Journal of virology 2009;83(11):5495-504.
2009: David Ben-Nathan; Orly Gershoni-Yahalom; Itzchak Samina; Yevgeny Khinich; Israel Nur; Orgad Laub; Ahuva Gottreich; Michael Simanov; Angel Porgador; Bracha Rager-Zisman; Nadav Orr
Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.
BMC infectious diseases 2009;9():18.
2008: Ilana Belmaker; Elina Bazarsky; Larissa Dukhan; Chamny Shlomo; Bracha Rager-Zisman
Two-dose measles immunization as a strategy to eliminate measles in the Middle East and Israel.
The Israel Medical Association journal : IMAJ 2008;10(8-9):640-5.
2007: Sebastien Herrmann; Boaz Leshem; Leslie Lobel; Hanna Bin; Ella Mendelson; David Ben-Nathan; Philippe Dussart; Angel Porgador; Bracha Rager-Zisman; Robert Marks
T7 phage display of Ep15 peptide for the detection of WNV IgG.
Journal of virological methods 2007;141(2):133-40.
2005: Ory Rouvio; Tatyana Dvorkin; Hila Amir-Kroll; Danit Atias; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland.
Vaccine 2005;23(27):3508-18.
2005: Sebastien Herrmann; Boaz Leshem; Shimi Landes; Bracha Rager-Zisman; Robert Marks
Chemiluminescent optical fiber immunosensor for the detection of anti-West Nile virus IgG.
Talanta 2005;66(1):6-14.
2004: Bracha Rager-Zisman; Elina Bazarsky; Agneta Skibin; Guy Tam; Shlomo Chamney; Ilana Belmaker; Iris Shai; Ella Kordysh; Diane E Griffin
Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children.
Clinical and diagnostic laboratory immunology 2004;11(5):913-8.
2004: A M Denman; Bracha Rager-Zisman
Viruses and autoimmune diseases--adapting Koch's postulates.
Autoimmunity reviews 2004;3(5):355-61.
2003: Bracha Rager-Zisman; David Ben-Nathan
Efficacy of prophylactic and therapeutic human immunoglobulin on West Nile virus infection.
The Israel Medical Association journal : IMAJ 2003;5(10):691.
2003: David Ben-Nathan; Shlomo Lustig; Guy Tam; Shahar Robinzon; Shraga Segal; Bracha Rager-Zisman
Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
The Journal of infectious diseases 2003;188(1):5-12.
2003: Bracha Rager-Zisman; Elina Bazarsky; Agneta Skibin; Shlomo Chamney; Ilana Belmaker; Iris Shai; Ella Kordysh; Diane E Griffin
The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children.
Vaccine 2003;21(19-20):2580-8.
1998: Shulamith Horowitz; Jacob Horowitz; L Hou; E Fuchs; Bracha Rager-Zisman; E Jacobs; Michael Alkan
Antibodies to mycoplasma fermentans in HIV-positive heterosexual patients: seroprevalence and association with AIDS.
The Journal of infection 1998;36(1):79-84.
1997: D Fishman; M Wolfson; E Bazarski; S Segal; Bracha Rager-Zisman
The effects of measles virus persistent infection on AP-1 transcription factor binding in neuroblastoma cells.
FEBS letters 1997;410(2-3):191-4.
1997: Elina Bazarsky; M Wolfson; D Galron; Y Granot; Shmuel Argov; Noah Isakov; Bracha Rager-Zisman
Persistent measles virus infection of murine neuroblastoma cells differentially affects the expression of PKC individual isoenzymes.
Virus genes 1997;15(3):227-34.
1996: Aaron Palmon; S Blagerman; S Tel-Or; M Pecht; N Trainin; Yigal Burstein; Bracha Rager-Zisman
Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2.
Antiviral research 1996;33(1):55-64.
1996: Rivka Ofir; Yacob Weinstein; E Bazarsky; S Blagerman; M Wolfson; Tony Hunter; Bracha Rager-Zisman
Tyrosine phosphorylation of measles virus P-phosphoprotein in persistently infected neuroblastoma cells.
Virus genes 1996;13(3):203-10.
1995: Y Segev; Rivka Ofir; Samuel Salzberg; A Heller; Yacob Weinstein; Noah Isakov; S Udem; M Wolfson; Bracha Rager-Zisman
Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells.
Journal of virology 1995;69(4):2480-5.
1994: Benjamin Sredni; Z Rosenthal-Galili; H Michlin; D Sobelman; Y Seger; S Blagerman; Yona Kalechman; Bracha Rager-Zisman
Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
Immunology letters 1994;43(3):159-65.
1994: Y Segev; Bracha Rager-Zisman; Noah Isakov; Sibylle Schneider-Schaulies; Volker ter Meulen; S Udem; S Segal; M Wolfson
Reversal of the measles virus-mediated increase of phosphorylating activity in persistently infected mouse neuroblastoma cells by anti-measles virus antibodies.
The Journal of general virology 1994;75 ( Pt 4)():819-27.
1993: T Ehrlich; O Wishniak; Noah Isakov; O Cohen; S Segal; Bracha Rager-Zisman; Jacob Gopas
The effect of H-ras expression on tumorigenicity and immunogenicity of Balb/c 3T3 fibroblasts.
Immunology letters 1993;39(1):3-8.
1993: Bracha Rager-Zisman; Y Segev; S Blagerman; Aaron Palmon; S Tel-Or; M Pecht; N Trainin; Yigal Burstein
Thymic humoral factor, THF-gamma 2, enhances immunotherapy of murine cytomegalovirus (MCMV) infection by both CD4+ and CD8+ immune T cells.
Immunology letters 1993;39(1):23-31.
1992: Jacob Gopas; T Ehrlich; O Cohen; O Wishniak; Michael A Tainsky; S Segal; Bracha Rager-Zisman; Noah Isakov
The H-ras oncogene regulates expression of 70- and 45-kDa cell-surface molecules whose expression correlates with tumor-cell immunogenicity.
International journal of cancer. Journal international du cancer 1992;52(2):329-35.
1992: Sibylle Schneider-Schaulies; U. Liebert; Y Segev; Bracha Rager-Zisman; M Wolfson; Volker ter Meulen
Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells.
Journal of virology 1992;66(9):5534-41.
1992: Jacob Gopas; D Itzhaky; Y Segev; Samuel Salzberg; B Trink; Noah Isakov; Bracha Rager-Zisman
Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.
Cancer immunology, immunotherapy : CII 1992;34(5):313-20.
1992: I Har-Vardi; Jacob Gopas; Bracha Rager-Zisman; G J Hammerling; S Segal; Mordechai Aboud
Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
Invasion & metastasis 1992;12(5-6):301-8.
1991: Bracha Rager-Zisman; Mordechai Aboud; Jacob Gopas; I Har-Vardi; G J Hämmerling; S Segal
Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Seminars in cancer biology 1991;2(5):329-36.
1991: M Wolfson; Jacob Gopas; A Katorza; S A Udem; S Segal; Bracha Rager-Zisman
Regulatory effects of persistent measles virus infection on tumorigenicity and protooncogene expression in neuroblastoma cells.
Cancer detection and prevention 1991;15(3):171-6.
1990: J M Schapiro; Y Segev; L Rannon; M Alkan; Bracha Rager-Zisman
Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine.
Journal of medical virology 1990;30(3):196-200.
1990: Bracha Rager-Zisman; F Zuckerman; Daniel Benharroch; M Pecht; Yigal Burstein; N Trainin
Therapy of a fatal murine cytomegalovirus infection with thymic humoral factor (THF-gamma 2) treated immune spleen cells.
Clinical and experimental immunology 1990;79(2):246-52.
1989: Jacob Gopas; Bracha Rager-Zisman; I Har-Vardi; G J Hammerling; M Bar-Eli; S Segal
NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
Journal of immunogenetics 1989;16(4-5):305-13.
1989: M Wolfson; A Katorza; S Segal; Bracha Rager-Zisman
Effect of persistent measles virus infection on protein kinase C activity and c-fos protooncogene expression in neuroblastoma cells.
FEBS letters 1989;250(2):367-70.
1989: Jacob Gopas; Bracha Rager-Zisman; M Bar-Eli; G J Hämmerling; S Segal
The relationship between MHC antigen expression and metastasis.
Advances in cancer research 1989;53():89-115.
1988: Bracha Rager-Zisman
Virus-induced autoimmunity.
Israel journal of medical sciences 1988;24(7):363-5.
1988: Jacob Gopas; S Segal; G Hammerling; M Bar-Eli; Bracha Rager-Zisman
Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells.
Immunology letters 1988;17(3):261-5.
1988: Bracha Rager-Zisman; Jacob Gopas; M Bar-Eli; I Har-Vardi; G J Hammerling; S Segal
NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells.
Advances in experimental medicine and biology 1988;233():151-60.
1988: Jacob Gopas; Bracha Rager-Zisman; M Bar-Eli; I Har-Vardi; G J Hammerling; S Segal
The immunobiology of metastatic processes: analysis of NK sensitivity and the metastatic potential of H-2 gene transfected fibrosarcoma cells.
Natural immunity and cell growth regulation 1988;7(3):155-62.
1988: Rivka Ofir; Yacob Weinstein; Bracha Rager-Zisman
Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
Natural immunity and cell growth regulation 1988;7(2):77-86.
1987: E Katorza; M Pecht; Ron N Apte; Daniel Benharroch; Yigal Burstein; N Trainin; Bracha Rager-Zisman
Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).
Clinical and experimental immunology 1987;70(2):268-75.
1987: Bracha Rager-Zisman; A Schattner
Differences in susceptibility to NK cell killing of two cloned sublines derived from a single clone.
Immunology letters 1987;15(4):269-75.